|
CTCF expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.042400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.893900E-02 |
| Normal-vs-Stage2 |
4.419800E-01 |
| Normal-vs-Stage3 |
8.986600E-01 |
| Normal-vs-Stage4 |
2.037400E-01 |
| Stage1-vs-Stage2 |
6.414400E-01 |
| Stage1-vs-Stage3 |
2.511800E-01 |
| Stage1-vs-Stage4 |
8.842200E-01 |
| Stage2-vs-Stage3 |
6.305200E-01 |
| Stage2-vs-Stage4 |
6.331800E-01 |
| Stage3-vs-Stage4 |
4.076400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.670200E-01 |
| Normal-vs-AfricanAmerican |
7.124400E-02 |
| Normal-vs-Asian |
3.950400E-01 |
| Caucasian-vs-AfricanAmerican |
3.125000E-01 |
| Caucasian-vs-Asian |
3.523600E-01 |
| AfricanAmerican-vs-Asian |
1.455370E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.048230E-01 |
| Normal-vs-Female |
9.290400E-01 |
| Male-vs-Female |
1.469400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.360200E-02 |
| Normal-vs-Extreme_Weight |
1.146970E-01 |
| Normal-vs-Obese |
8.463400E-01 |
| Normal-vs-Extreme_Obese |
1.684650E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.800800E-01 |
| Normal_Weight-vs-Obese |
6.785700E-02 |
| Normal_Weight-vs-Extreme_Obese |
7.576200E-01 |
| Extreme_Weight-vs-Obese |
2.018200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.937400E-01 |
| Obese-vs-Extreme_Obese |
1.786830E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.928000E-01 |
| Normal-vs-Age(41-60Yrs) |
8.250000E-01 |
| Normal-vs-Age(61-80Yrs) |
5.504200E-02 |
| Normal-vs-Age(81-100Yrs) |
8.538200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.898800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.531600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.969700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.616100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.296400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.370400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.795200E-01 |
| Normal-VS-Type2 PRCC |
3.456200E-03 |
| Normal-VS-KIRP CIMP |
4.730600E-01 |
| Normal-VS-Unclassified PRCC |
6.857400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.718540E-03 |
| Type1 PRCC-VS-KIRP CIMP |
6.739600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.779600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.330400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.278100E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
8.386200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.359740E-02 |
| Normal-vs-N1 |
3.801000E-01 |
| Normal-vs-N2 |
2.493800E-02 |
| N0-vs-N1 |
8.503800E-03 |
| N0-vs-N2 |
4.823400E-01 |
| N1-vs-N2 |
4.450000E-02 |
|
|
